| Veritas Therapeutics Inc. Patent applications |
| Patent application number | Title | Published |
|---|
| 20100298418 | Assay for measuring plasma FGL-2 and methods and uses thereof - The disclosure relates to methods for identifying a subject having elevated FGL2 plasma levels, the method comprising the step of assaying a plasma sample from the subject to determine a level of FGL2, wherein a level above control indicates the subject has elevated FGL2 levels. Diagnostic methods, methods of monitoring prognosis and methods of medical treatment relating to viral hepatitis are also provided. The disclosure also provides assays and kits useful in the diagnosis of a viral hepatitis associated with elevated FGL2. | 11-25-2010 |
| 20100048486 | Use of Soluble Fgl2 As An Immunosuppressant - Methods and compositions for inducing immune suppression are disclosed. The methods involve administering an effective amount of a soluble fgl2 protein or a nucleic acid encoding a soluble fgl2 protein. The methods are useful in preventing graft rejection, autoimmune disease, and allergies. | 02-25-2010 |
